BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2688101)

  • 21. Point mutations modifying the thrombin inhibition kinetics and antithrombotic activity in vivo of recombinant hirudin.
    Degryse E; Acker M; Defreyn G; Bernat A; Maffrand JP; Roitsch C; Courtney M
    Protein Eng; 1989 Mar; 2(6):459-65. PubMed ID: 2710782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
    Koch C; Whitechurch O; Cordier P; Roitsch C
    Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of expression of an annexin V-hirudin chimeric protein in Escherichia coli.
    Yuan H; Yang X; Hua ZC
    Microbiol Res; 2004; 159(2):147-56. PubMed ID: 15293949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of the anticoagulant hirudin: its biotechnological production and clinical practice.
    Sohn JH; Kang HA; Rao KJ; Kim CH; Choi ES; Chung BH; Rhee SK
    Appl Microbiol Biotechnol; 2001 Dec; 57(5-6):606-13. PubMed ID: 11778867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hirudin variants production by genetic engineered microbial factory.
    Zhang J; Lan N
    Biotechnol Genet Eng Rev; 2018 Oct; 34(2):261-280. PubMed ID: 30095033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of secreted recombinant proteins from Escherichia coli.
    Le HV; Trotta PP
    Bioprocess Technol; 1991; 12():163-81. PubMed ID: 1367083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization.
    Scacheri E; Nitti G; Valsasina B; Orsini G; Visco C; Ferrera M; Sawyer RT; Sarmientos P
    Eur J Biochem; 1993 May; 214(1):295-304. PubMed ID: 7685281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel method of expression and purification of hirudin based on pBAD TOPO, pTYB12 vectors and gene synthesis.
    Kochanowski R; Kotłowski R; Szweda P
    Protein Expr Purif; 2006 Nov; 50(1):25-30. PubMed ID: 16857385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
    Heim J; Takabayashi K; Meyhack B; Märki W; Pohlig G
    Eur J Biochem; 1994 Dec; 226(2):341-53. PubMed ID: 8001551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and purification of recombinant hirudin].
    Guo J; Wang H; Gu J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):146-8. PubMed ID: 11243147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced production of anticoagulant hirudin in recombinant Saccharomyces cerevisiae by chromosomal delta-integration.
    Kim MD; Rhee SK; Seo JH
    J Biotechnol; 2001 Jan; 85(1):41-8. PubMed ID: 11164961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring a Hirudin variant from nonhematophagous leeches: Unraveling full-length sequence, alternative splicing, function, and potential as a novel anticoagulant polypeptide.
    Yi X; Liu J; Zang E; Tian Y; Liu J; Shi L
    J Ethnopharmacol; 2024 Aug; 330():118257. PubMed ID: 38677578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiae.
    Riehl-Bellon N; Carvallo D; Acker M; Van Dorsselaer A; Marquet M; Loison G; Lemoine Y; Brown SW; Courtney M; Roitsch C
    Biochemistry; 1989 Apr; 28(7):2941-9. PubMed ID: 2663064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin functions and antithrombotic intervention.
    Fenton JW
    Thromb Haemost; 1995 Jul; 74(1):493-8. PubMed ID: 8578512
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of the specific activity of recombinant hirudin.
    Eric D
    Thromb Res; 1990 Dec; 60(6):433-43. PubMed ID: 2082477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of hirudins.
    Fink E
    Semin Thromb Hemost; 1989 Jul; 15(3):283-7. PubMed ID: 2688100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.